Key facts
- Judi Health’s last known valuation is $3.3B (Sep 2025).
- It has raised $762.0M; the latest was Later Stage VC ($400.0M) in Sep 2025.
- Notable investors include Alumni Ventures, General Catalyst, F-Prime Capital, B Capital Group, 9Yards Capital — 26 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 26 names
- ·Watchlist + deal alerts for Judi Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Judi Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Judi Health
Developer of a pharmacy benefit management platform designed for cost-effective prescription drug coverage. The company's platform centralizes pharmacy benefit operations, integrating real-time claims processing, formulary management, and rebate transparency, enabling health plan administrators to streamline drug pricing, improve access to medications, and ensure regulatory compliance.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2017
- Employees
- 822
- Website
- judi.health/
- Ownership
- Privately Held (backing)
Judi Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Judi Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Judi Health in its N-PORT filings yet. We sweep new filings monthly.